Patent assignee · CA · COMPANY

XBIOTECH INC.

33Patents
33Active
33Granted
50Portfolio score

Filing activity: Jul 26, 2006 → Jun 21, 2022 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8034337B2 Interleukin-1α antibodies Physics 1,007 Active
US8388969B2 Interleukin-1 alpha antibodies and methods of use Physics 13 Active
US9486523B2 Compositions and methods for treating and preventing Staphylococcus aureus infections Chemistry; Metallurgy 13 Active
US8388956B2 Interleukin-1 alpha antibodies and methods of use Physics 13 Active
US8242074B2 Modulation of the amount or function of pathogenic CD14+CD16+ monocytes Human Necessities 12 Active
US9416172B2 Compositions and methods for treating and preventing Staphylococcus aureus infections Chemistry; Metallurgy 12 Active
US8679489B2 Inhibiting cell migration Physics 7 Active
US9840558B2 Human antibody specific for interleukin-1alpha Physics 7 Active
US8784817B2 Method for killing IL-1 alpha expressing cells Physics 7 Active
US8546331B2 Modulation of pathogenic CD14+/CD16+ monocytes Human Necessities 6 Active
US10202449B2 Cachexia treatment Chemistry; Metallurgy 5 Active
US9783598B2 Compositions and methods for treating and preventing Staphylococcus aureus infections Chemistry; Metallurgy 4 Active
US9809649B2 Cachexia treatment Chemistry; Metallurgy 3 Active
US10214581B2 Compositions and methods for treating and preventing Staphylococcus aureus infections Chemistry; Metallurgy 3 Active
US10294296B2 Treatment for neoplastic diseases Chemistry; Metallurgy 3 Active
US9181338B2 Human antibody specific for IL-1alpha Physics 3 Active
US8187817B2 Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies Human Necessities 2 Active
US10577410B2 Compositions and methods for treating and preventing Staphylococcus aureus infections Chemistry; Metallurgy 2 Active
US8962814B2 Interleukin-1α antibodies and methods of use Physics 2 Active
US8956831B2 Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α Physics 2 Active
US9902769B2 Treatment of dermatological pathologies Chemistry; Metallurgy 1 Active
US9988447B2 Treatment of diabetes Human Necessities 1 Active
US8865175B2 Increasing anti-IL-1α antibodies in a subject Human Necessities 1 Active
US9545441B2 Treatment of diabetes Human Necessities 1 Active
US9724409B2 Treatment of inflammatory skin disease Human Necessities 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.